Publications
Detailed Information
Differentiating radiation necrosis from tumor recurrence in high-grade gliomas: Assessing the efficacy of (18)F-FDG PET, (11)C-methionine PET and perfusion MRI
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Yong Hwy | - |
dc.contributor.author | Oh, So Won | - |
dc.contributor.author | Lim, You Jung | - |
dc.contributor.author | Park, Chul-Kee | - |
dc.contributor.author | Kang, Keon Wook | - |
dc.contributor.author | Chang, Kee Hyun | - |
dc.contributor.author | Jung, Hee-Won | - |
dc.contributor.author | Lee, Se-Hoon | - |
dc.date.accessioned | 2012-06-27T08:17:24Z | - |
dc.date.available | 2012-06-27T08:17:24Z | - |
dc.date.issued | 2010-11 | - |
dc.identifier.citation | CLINICAL NEUROLOGY AND NEUROSURGERY; Vol.112 9; 758-765 | ko_KR |
dc.identifier.issn | 0303-8467 | - |
dc.identifier.uri | https://hdl.handle.net/10371/77647 | - |
dc.description.abstract | Purpose: The authors analyzed the characteristics of perfusion magnetic resonance imaging (MRI), (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET) and (11)C-methionine (MET) PET to compare the efficacies of these modalities in making the distinction between radiation necrosis and tumor recurrence of high-grade glioma. Patients and methods: Ten patients were evaluated with dynamic susceptibility contrast perfusion MRI, (11)C-MET PET and (18)F-FDG PET to visualize gadolinium-enhanced lesions during the post-radiation follow-up period. In the perfusion MRI, four regions of interest (ROIs) were identified and average values were calculated. A reference ROI of the same size was defined in the contralateral white matter to obtain the relative cerebral blood volume (rCBV). After coregistering the PET images with the MRI, we measured the maximum uptake values of the lesion and of the contralateral cerebral white matter as reference area to calculate the L(max)/R(max) ratio. Results: The rCBV was higher in the recurrence group than in the necrosis group (p = 0.010). There was no difference between groups in terms of the L(max)/R(max) ratio as derived from the 18F-FDG and (11)C-MET PET. Conclusion:A quantitative rCBV as calculated from a perfusion MRI scan might be superior to the L(max)/R(max) ratio as derived from (18)F-FDG and (11)C-MET PET in order to distinguish a recurrence of high-grade glioma from radiation necrosis. (C) 2010 Elsevier B.V. All rights reserved. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | ELSEVIER SCIENCE BV | ko_KR |
dc.subject | High-grade glioma | ko_KR |
dc.subject | Recurrence | ko_KR |
dc.subject | Radiation necrosis | ko_KR |
dc.subject | PET | ko_KR |
dc.subject | Perfusion MRI | ko_KR |
dc.title | Differentiating radiation necrosis from tumor recurrence in high-grade gliomas: Assessing the efficacy of (18)F-FDG PET, (11)C-methionine PET and perfusion MRI | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 김용휘 | - |
dc.contributor.AlternativeAuthor | 오소원 | - |
dc.contributor.AlternativeAuthor | 임유정 | - |
dc.contributor.AlternativeAuthor | 박철기 | - |
dc.contributor.AlternativeAuthor | 이세훈 | - |
dc.contributor.AlternativeAuthor | 강건욱 | - |
dc.contributor.AlternativeAuthor | 정희원 | - |
dc.contributor.AlternativeAuthor | 장기현 | - |
dc.identifier.doi | 10.1016/j.clineuro.2010.06.005 | - |
dc.citation.journaltitle | CLINICAL NEUROLOGY AND NEUROSURGERY | - |
dc.description.citedreference | Arvinda HR, 2009, J NEURO-ONCOL, V94, P87, DOI 10.1007/s11060-009-9807-6 | - |
dc.description.citedreference | Peca C, 2009, CLIN NEUROL NEUROSUR, V111, P331, DOI 10.1016/j.clineuro.2008.11.003 | - |
dc.description.citedreference | Hu LS, 2009, AM J NEURORADIOL, V30, P552, DOI 10.3174/ajnr.A1377 | - |
dc.description.citedreference | Young GS, 2009, AM J NEURORADIOL, V30, P575, DOI 10.3174/ajnr.A1239 | - |
dc.description.citedreference | Barajas RF, 2009, AM J NEURORADIOL, V30, P367, DOI 10.3174/ajnr.A1362 | - |
dc.description.citedreference | Tie J, 2008, J CLIN NEUROSCI, V15, P1327, DOI 10.1016/j.jocn.2007.12.008 | - |
dc.description.citedreference | Hatakeyama T, 2008, EUR J NUCL MED MOL I, V35, P2009, DOI 10.1007/s00259-008-0847-5 | - |
dc.description.citedreference | Kato T, 2008, AM J NEURORADIOL, V29, P1176, DOI 10.3174/ajnr.A1008 | - |
dc.description.citedreference | Brandsma D, 2008, LANCET ONCOL, V9, P453 | - |
dc.description.citedreference | Terakawa Y, 2008, J NUCL MED, V49, P694, DOI 10.2967/jnumed.107.048082 | - |
dc.description.citedreference | Di Costanzo A, 2008, RADIOL MED, V113, P134, DOI 10.1007/s11547-008-0232-2 | - |
dc.description.citedreference | Chen W, 2007, J CLIN ONCOL, V25, P4714, DOI 10.1200/JCO.2006.10.5825 | - |
dc.description.citedreference | Zeng QS, 2007, INT J RADIAT ONCOL, V68, P151, DOI 10.1016/j.ijrobp.2006.12.001 | - |
dc.description.citedreference | Sundgren PC, 2006, MAGN RESON IMAGING, V24, P1131, DOI 10.1016/j.mri.2006.07.008 | - |
dc.description.citedreference | Borbely K, 2006, J NEUROL SCI, V246, P85, DOI 10.1016/j.jns.2006.02.015 | - |
dc.description.citedreference | Rachinger W, 2005, NEUROSURGERY, V57, P505, DOI 10.1227/01.NEU.0000171642.49553.B0 | - |
dc.description.citedreference | Stupp R, 2005, NEW ENGL J MED, V352, P987 | - |
dc.description.citedreference | Van Laere K, 2005, EUR J NUCL MED MOL I, V32, P39, DOI 10.1007/s00259-004-1564-3 | - |
dc.description.citedreference | Hustinx R, 2005, RADIOL CLIN N AM, V43, P35, DOI 10.1016/j.rcl.2004.09.009 | - |
dc.description.citedreference | Kim S, 2005, EUR J NUCL MED MOL I, V32, P52, DOI 10.1007/s00259-004-1598-6 | - |
dc.description.citedreference | Spaeth N, 2004, J NUCL MED, V45, P1931 | - |
dc.description.citedreference | Downey RJ, 2004, J CLIN ONCOL, V22, P3255, DOI 10.1200/JCO.2004.11.109 | - |
dc.description.citedreference | Giammarile F, 2004, J NEURO-ONCOL, V68, P263 | - |
dc.description.citedreference | Tsuyuguchi N, 2004, ANN NUCL MED, V18, P291 | - |
dc.description.citedreference | Hein PA, 2004, AM J NEURORADIOL, V25, P201 | - |
dc.description.citedreference | Chan YL, 2003, J COMPUT ASSIST TOMO, V27, P674 | - |
dc.description.citedreference | Ichinose T, 2003, NEUROL MED-CHIR, V43, P461 | - |
dc.description.citedreference | Wong TZ, 2002, NEUROIMAG CLIN N AM, V12, P615 | - |
dc.description.citedreference | Schlemmer HP, 2002, NEURORADIOLOGY, V44, P216, DOI 10.1007/s002340100703 | - |
dc.description.citedreference | Chao ST, 2001, INT J CANCER, V96, P191 | - |
dc.description.citedreference | Meyer PT, 2001, EUR J NUCL MED, V28, P165 | - |
dc.description.citedreference | Kumar AJ, 2000, RADIOLOGY, V217, P377 | - |
dc.description.citedreference | Langleben DD, 2000, J NUCL MED, V41, P1861 | - |
dc.description.citedreference | Fuss M, 2000, INT J RADIAT ONCOL, V48, P53 | - |
dc.description.citedreference | Sugahara T, 2000, AM J NEURORADIOL, V21, P901 | - |
dc.description.citedreference | Knopp EA, 1999, RADIOLOGY, V211, P791 | - |
dc.description.citedreference | Sugahara T, 1998, AM J ROENTGENOL, V171, P1479 | - |
dc.description.citedreference | Ricci PE, 1998, AM J NEURORADIOL, V19, P407 | - |
dc.description.citedreference | Hazle JD, 1997, JMRI-J MAGN RESON IM, V7, P1084 | - |
dc.description.citedreference | ROELCKE U, 1995, J NEUROL SCI, V132, P20 | - |
dc.description.citedreference | FORSYTH PA, 1995, J NEUROSURG, V82, P436 | - |
dc.description.citedreference | KAHN D, 1994, AM J ROENTGENOL, V163, P1459 | - |
dc.description.citedreference | ARONEN HJ, 1994, RADIOLOGY, V191, P41 | - |
dc.description.citedreference | CHIANG CS, 1993, RADIOTHER ONCOL, V29, P60 | - |
dc.description.citedreference | MACDONALD DR, 1990, J CLIN ONCOL, V8, P1277 | - |
dc.description.citedreference | PAULUS W, 1989, CANCER, V64, P442 | - |
dc.description.citedreference | PATRONAS NJ, 1982, RADIOLOGY, V144, P885 | - |
dc.description.citedreference | WALKER MD, 1978, J NEUROSURG, V49, P333 | - |
dc.description.tc | 4 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.